Fertility and Ovarian Reserve Panel

Your body does not give you a straightforward fertility countdown. You can have regular periods and still be running low on eggs. You can ovulate every month and still have a hormone imbalance that makes conception unlikely. A single blood test cannot answer the question "Can I get pregnant?" but six tests drawn together can map the major hormonal systems that determine whether pregnancy is possible, likely, or at risk.

This panel measures the three layers of fertility that matter most: how many eggs remain in your ovaries, whether the hormonal signals driving ovulation are functioning correctly, and whether thyroid or prolactin problems are silently interfering. Ordering these tests together, in a single blood draw, gives you a snapshot that no individual test can provide on its own.

What This Panel Reveals

The six tests in this panel cover three distinct clinical domains. Understanding each domain, and how the tests within it interact, is what makes this panel far more useful than any single hormone level.

Egg Supply

Anti-Mullerian hormone (AMH) is the closest thing to a direct readout of your remaining egg supply. It is produced by the small, developing follicles (tiny fluid-filled sacs that each contain an egg) in your ovaries, and its level in your blood reflects the size of that pool. Unlike most reproductive hormones, AMH stays relatively stable throughout your menstrual cycle, so it can be drawn on any day. In a study of over 17,000 women presenting to U.S. fertility centers, AMH showed a clear, predictable decline with age, dropping from a median of roughly 3.5 ng/mL in the mid-20s to below 1.0 ng/mL by the early 40s.

AMH below 1.0 ng/mL at any age is generally considered a sign of diminished ovarian reserve (DOR), the medical term for a smaller-than-expected egg supply. But AMH alone does not tell you everything. That is why this panel pairs it with FSH, which reflects how hard your brain is working to stimulate your ovaries. When the egg supply is low, the pituitary gland in your brain sends out more follicle-stimulating hormone (FSH) to compensate. An elevated day-3 FSH (above 10 IU/L) is an independent marker of diminished reserve.

Ovulatory Signaling

Ovulation depends on a tightly choreographed conversation between your brain and your ovaries. The pituitary gland releases two signaling hormones, FSH and luteinizing hormone (LH), that tell the ovaries when to grow a follicle and when to release an egg. Estradiol (a form of estrogen) is the ovary's reply, confirming that a follicle is growing and maturing.

When these signals fall out of balance, ovulation can stall or stop entirely. In polycystic ovary syndrome (PCOS), a condition affecting roughly 6% to 12% of women of reproductive age, LH is often disproportionately elevated relative to FSH. An LH-to-FSH ratio above 2:1 or 3:1 is a pattern seen in some women with PCOS, though current guidelines do not consider it a reliable diagnostic criterion on its own. Detecting this ratio requires measuring both hormones in the same draw, ideally on day 2 or 3 of the menstrual cycle.

Estradiol drawn on day 3 serves a specific gatekeeper role. If estradiol is elevated early in the cycle (above roughly 60 to 80 pg/mL), it can artificially suppress FSH by signaling the brain to reduce its output, making FSH look normal when it is actually high. In other words, a "normal" FSH result is only trustworthy if day-3 estradiol is also in its expected range. This is a pattern you can only catch by measuring both tests at the same time.

Hidden Hormonal Disruptors

Prolactin and thyroid-stimulating hormone (TSH) are not ovarian hormones, but both can shut down fertility from a distance. Prolactin is the hormone that triggers milk production after childbirth, but when it is elevated outside of pregnancy or nursing (a condition called hyperprolactinemia), it suppresses the release of GnRH, a brain hormone that controls the production of FSH and LH. That suppression, in turn, reduces FSH and LH output, which can halt ovulation entirely. Elevated prolactin is found in roughly 15% to 20% of women with unexplained absent periods.

TSH screens for thyroid dysfunction, which affects an estimated 2% to 4% of women of reproductive age. Both an underactive thyroid (hypothyroidism) and an overactive thyroid (hyperthyroidism) can impair ovulation and raise the risk of miscarriage. The American Thyroid Association recommends that women trying to conceive maintain a TSH below 2.5 mIU/L, a tighter target than the standard laboratory reference range. A TSH that looks "normal" by lab standards may still be too high for optimal fertility.

How to Read Your Results Together

Individual results matter, but the real diagnostic power of this panel comes from reading results as patterns. The table below covers the most common combinations and what they suggest.

A TSH above 2.5 mIU/L in a woman trying to conceive warrants treatment even if the value falls within the laboratory's "normal" range. Subclinical hypothyroidism (mildly elevated TSH with normal thyroid hormone levels) has been associated with a higher risk of miscarriage and impaired implantation in multiple large studies. If TSH is elevated, adding thyroid antibody testing (Anti-TPO) helps determine whether autoimmune thyroid disease is the cause, since thyroid autoimmunity itself has been linked to poorer fertility outcomes independent of TSH level.

When Results Can Be Misleading

Timing is everything with this panel. FSH, LH, and estradiol must be drawn on day 2 or 3 of the menstrual cycle (counting the first day of full flow as day 1) to be clinically meaningful. Drawing them later in the cycle will produce values that reflect follicle development or ovulation, not baseline ovarian function.

Prolactin is sensitive to stress, exercise, meals, and even the act of having blood drawn. A mildly elevated result (between 25 and 40 ng/mL) should be confirmed with a repeat test drawn after sitting calmly for 15 to 20 minutes. Certain medications, including antipsychotics, some antidepressants, and anti-nausea drugs, can also raise prolactin significantly.

AMH can be drawn on any day of the cycle and is not affected by hormonal contraceptives in the same way FSH and LH are. However, AMH may be transiently suppressed in women currently using combined oral contraceptives. If you are on hormonal birth control, discuss timing with your provider.

Tracking Over Time

A single panel gives you a snapshot. Serial testing, repeated every 6 to 12 months, reveals a trajectory. AMH, in particular, becomes far more useful when tracked over time. A steady AMH tells you your reserve is stable. A rapidly falling AMH, even if the current level is still "normal," may signal that your window for conception is narrowing faster than expected.

Women in their late 20s and 30s who are not yet ready to conceive but want to preserve the option should consider testing at least once a year. If AMH is declining quickly, that information can change the timeline for egg freezing or family planning in a way that waiting for a single future test cannot.

TSH and prolactin should be rechecked whenever a new medication is started, symptoms change, or treatment for an identified issue is underway. For women being treated for hypothyroidism, TSH should be monitored every 4 to 6 weeks after a dose adjustment until stable.

What to Do with Your Results

If your AMH is low, your FSH is elevated, or both, the most important next step is a conversation with a reproductive endocrinologist about your timeline. This does not mean you cannot conceive, but it does mean the window may be shorter than average, and options like egg freezing or accelerated family planning are worth discussing now rather than later.

If your LH-to-FSH ratio suggests PCOS, adding androgen levels (total testosterone, DHEA sulfate) and insulin resistance markers (fasting insulin, HOMA-IR) will round out the diagnosis. PCOS is highly treatable, but it requires different strategies than other causes of infertility.

If prolactin is elevated, the cause must be identified. Most prolactin-producing pituitary tumors (prolactinomas) are small and respond well to medication. Drug-induced hyperprolactinemia may resolve with a medication switch. If TSH is above 2.5 mIU/L, levothyroxine (a thyroid hormone replacement medication) is straightforward and often improves both conception rates and pregnancy outcomes.

For women with entirely normal results, this panel provides powerful reassurance and a baseline. You now know your reserve is intact, your ovulatory signaling is balanced, and no hidden disruptors are at play. Retest annually to stay ahead of changes.